(Q33863978)

English

International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997. (English)

1 reference

Europe PubMed Central

29 July 2017

pharmacotherapy

0 references

author name string

Uhlenhuth EH

1

1 reference

Europe PubMed Central

29 July 2017

Balter MB

2

1 reference

Europe PubMed Central

29 July 2017

Ban TA

3

1 reference

Europe PubMed Central

29 July 2017

Yang K

4

1 reference

Europe PubMed Central

29 July 2017

publication date

1 January 1999

1 reference

Europe PubMed Central

29 July 2017

Depression and Anxiety

1 reference

Europe PubMed Central

29 July 2017

9

1 reference

Europe PubMed Central

29 July 2017

107-116

1 reference

Europe PubMed Central

29 July 2017

3

1 reference

Europe PubMed Central

29 July 2017

A naturalistic study of imipramine in panic disorder and agoraphobia.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6394%281999%299%3A3%3C107%3A%3AAID-DA2%3E3.0.CO%3B2-T

21 January 2018

Advances in the psychosocial treatment of anxiety disorders. Implications for national health care

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6394%281999%299%3A3%3C107%3A%3AAID-DA2%3E3.0.CO%3B2-T

21 January 2018

Clinical psychopharmacologic practice. The need for developing a research base.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6394%281999%299%3A3%3C107%3A%3AAID-DA2%3E3.0.CO%3B2-T

21 January 2018

The lack of selection bias in a snowball sampled case-control study on drug abuse.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6394%281999%299%3A3%3C107%3A%3AAID-DA2%3E3.0.CO%3B2-T

21 January 2018

Recent developments in the psychopharmacology of anxiety disorders

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6394%281999%299%3A3%3C107%3A%3AAID-DA2%3E3.0.CO%3B2-T

21 January 2018

Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6394%281999%299%3A3%3C107%3A%3AAID-DA2%3E3.0.CO%3B2-T

21 January 2018

International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6394%281999%299%3A3%3C107%3A%3AAID-DA2%3E3.0.CO%3B2-T

21 January 2018

Response of panic disorder to fixed doses of alprazolam or imipramine.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6394%281999%299%3A3%3C107%3A%3AAID-DA2%3E3.0.CO%3B2-T

21 January 2018

Identifiers

10.1002/(SICI)1520-6394(1999)9:3<107::AID-DA2>3.0.CO;2-T

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33863978&oldid=1605656848"